|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 317/26 | (2006.01) |
| C07D 317/42 | (2013.01) | ||
| C07D 493/08 | (2006.01) | ||
| C07D 493/08 | (2013.01) | ||
| C07D 317/42 | (2006.01) | ||
| C07D 317/26 | (2013.01) | ||
| A61K 31/70 | (2006.01) |
| (11) | Number of the document | 3466431 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18201632.9 |
| Date of filing the European patent application | 2014-03-10 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361783128 P | 2013-03-14 | US | |
| 201361887504 P | 2013-10-07 | US | |
| 201361912252 P | 2013-12-05 | US |
| (72) |
Brenek, Steven J. , US
Caron, Stephanie , US
Nelson, Jade D. , US
Webster, Mark, E. , US
Weekly, Rodney Matthew , US
|
| (73) |
MSD International GmbH ,
Weystrasse 20, 6000 Luzern,
CH
|
| (54) | CRYSTALLINE FORMS AND METHODS FOR PREPARING SGLT2 INHIBITORS |
| CRYSTALLINE FORMS AND METHODS FOR PREPARING SGLT2 INHIBITORS |